Abstract:OBJECTIVE:To develop a new kind of vector system called gene-viral vector, which combines the advantages of gene and virus therapies.METHODS:Using recombinant technology, an anti-tumor gene was inserted into the genome of replicative virus specific for tumor cells. The cell killing effect, reporter gene expression of the green fluorescence protein, anti-tumor gene expression of mouse interleukin-12 (mIL-12) and replication of virus were observed by the methods of cell pathology, fluorescence microscopy, ELISA and electron microscopy, respectively.RESULTS:A new kind of gene-viral vector system of adenovirus, in which the E1b-55 kD gene was deleted but the E1a gene was preserved, was constructed. The vector system, like the replicative virus ONYX-015, replicated and proliferated in tumor cells but not in normal ones. Our vector had an advantage over ONYX-015 in that it carried different kinds of anti-tumor genes to enhance its therapeutic effect. The reporter gene expression of the green fluorescence protein in tumor cells was much better than the adenovirus vector employed in conventional gene the rapy, and the expression in our vector system was as low as or even less than that in the conventional adenovirus gene therapy system. Similar results were observed in experiments with this vector system carrying the anti-tumor gene mIL-12. Replication and proliferation of the virus carrying the mIL-12 gene in tumor cells were confirmed by electron microscopy.CONCLUSIONS:Gene-viral vectors are new vectors with an anti-tumor gene inserted into the genome of replicative virus specific for tumor cells. Because of the specific replication and proliferation of the virus in tumor cells, expression of the anti-tumor gene is increased hundreds to thousands of times. This approach takes full advantages of gene therapy and virus therapy to enhance the effect on the tumor. It overcomes the disadvantages of conventional gene therapy, such as low transfer rate, low gene expression, lack of target tropism, and low anti-tumor activity. We believe that this is a promising means for future tumor treatment.

A novel inducible lentiviral system for multi-gene expression with human HSP70 promoter and tetracycline-induced promoter

Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.

Construction of novel conditional transgenic vectors for molecular therapy based on the Tet-On system and flanked with insulators in a single plasmid

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells

Inducible and Reversible Transgene Expression in Human Stem Cells after Efficient and Stable Gene Transfer

A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression

An Improved Tet-on System for Gene Expression in Neurons Delivered by a Single Lentiviral Vector.

Transactivator and Structurally Optimized Inducible Lentiviral Vectors.

Construction of a Novel Gene Therapy Lentiviral Vector for Drug Resistant Selection and Detection in Vivo

Construction of a Lentivirus Vector Expressing Three Reporter Genes and Its Experimental Study

Construction and Verification of Novel Lentiviral Expression Vector Plox-Cmv-e/p Based on Cre-LoxP System

Lentiviral Vectors with Amplified Beta Cell-Specific Gene Expression

Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo

Abstract# 3787: A novel hTERT promoter driven E1A therapeutic for ovarian cancer

Progression and Application of HIV-1-derived Lentivectors

Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector

653. the Controlled Transgene Expression in Oncolytic Adenoviral Vectors with Major Late Promoter for Therapy of Cancer

Gene-viral Vectors: a Promising Way to Target Tumor Cells and Express Anticancer Genes Simultaneously.

Construction of Tumor-specific Oncolytic Adenovirus Vector and its Primary Study on Selective Expression in Tumor Cells

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.